Morphocell Technologies

We are proud to support the @StemCellNetwork for the #TMM2024. Meet our team during the conference, come see us at Morphocell’s booth and don’t miss our session on Tissue-engineered products on Nov 5 at lunchtime

We’re thrilled to welcome Dr. Paul K. Wotton to our Board of Directors! With 30+ years in biotech & #CellTherapy, Dr. Wotton’s expertise will drive our mission to deliver life-changing treatments for sever organ deficiencies. morphocell.com/updates/paul-w…

🚀 Exciting news! Morphocell welcomes Dr. Vincent Ling as our new Chief Business Officer! 🎉 With 30 years of experience in biotech & pharma, Dr. Ling is set to lead our business development efforts. Welcome aboard, Vincent! #CellTherapy #LiverDisease morphocell.com/updates/new-ch…

Thanks to our sponsors for their incredible support! This event would not be possible without you! @StemCellNetwork @MorphocellTech @STEMCELLTech @CATTI_Training @LDI_ILD @McGillSBMS @TheNeuro_MNI @McGillMed

Big news! We're excited to welcome Patrick Bedford as our new VP of Regulatory Affairs. With 18+ years in cell & gene therapy, Patrick is set to lead our regulatory strategies to new heights. #CellTherapy #LiverDisease morphocell.com/updates/new-vp…

It's #WorldLiverDay, let's take a moment to celebrate the inspiring courage and resilience of all children and adults living with liver disease. As on any other day, we are working to give them hope

J’ai récemment visité Morphocell, une entreprise de #Laval dont la technologie va littéralement changer la vie des personnes atteintes d’une insuffisance hépatique. Je suis vraiment fier de constater que leur première ronde de financement a été un succès!🔬bit.ly/3VNjLyu

Exciting news! 🙌 @MorphocellTech announced US$40M in Series A financing to advance its first therapeutic product, ReLiver®, a novel cell therapy platform that promises to transform the treatment of liver disease. Read more. ➡️ stemcellnetwork.ca/scn-industry-p…

Grande nouvelle! 🙌 @morphocelltech a annoncé avoir obtenu un financement de série A de 40 millions de dollars américains pour faire progresser son premier produit thérapeutique, ReLiver®,

@CQDM_Canada . We share. Congratulations to @MorphocellTech who today announced the completion of US$40 Million Series A financing to transform the treatment of liver disease. Read the Press Release here: morphocell.com/updates/morpho…

We are proud to announce the closing of a US$40 million Series A financing to transform the treatment of liver disease. #CellTherapy #EngineeringHope #LiverHealth morphocell.com/updates/morpho…

Nous sommes heureux de soutenir l'entreprise innovante Morphocell pour favoriser la recherche et développement de son produit, le ReLiver, une solution de médecine régénératrice destinée à des dizaines de milliers d’adultes et d'enfants⚕️ investquebec.com/quebec/fr/sall… @MorphocellTech

Morphocell’s growing, enthusiastic team with the minister @Cskeete, the mayor @stephaneboyer_ and @InvestQuebec. We work together to bring groundbreaking #CellTherapy for #LiverDisease to children and adults in need in #Quebec and all around the world

Nous avons eu le privilège d’accueillir le ministre @Cskeete avec l’équipe du @InvestQuebec et @stephaneboyer_, maire de #Laval. Leur appui renforce notre détermination à developer des thérapies cellulaires innovantes #Merci #Québec #SciencesDeLaVie

Visite captivante chez @MorphocellTech, pionnier de la biotechnologie à #Laval. Leur technologie « ReLiver » offre un espoir aux patients en déficience hépatiques sans recours à la greffe. Investissement=750K$ par @InvestQuebec témoigne de leur potentiel!🧬bit.ly/49vAHNL

Le ministre @Cskeete convie les médias à une visite de l’entreprise @MorphocellTech, demain 9h45 à @villedelavalqc. 🧬 bit.ly/3wxlZY1

🌟 Exciting News! 🌟 Morphocell Technologies welcomes Dr. Calley Hirsch as our new VP of Preclinical Development. A leading expert in cell therapy, Calley is set to propel our innovations to new heights. #CellTherapy #LiverDisease morphocell.com/updates/new-vp…

Thrilled to announce that Morphocell is a finalist in the 2023 ADRIQ Innovation Awards! We are proud to represent Quebec’s vibrant innovation landscape, and grateful for our amazing team. #ADRIQ2023 #Innovation #CellTherapy

Join us for #TMM2023 Plenary 6 as we talk about cell-based #RegenMed, chaired by Sara Vasconcelos @yyzscientist & George Cairns with an excellent lineup of speakers Stefan Irion @bigosi, @stemcellberto, Véronique Moulin, & @mcnostro! Thx to @MorphocellTech for sponsoring!